05-23-0500 Bradykinin - CAS 58-82-2 - Calbiochem

05-23-0500
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical FormulaCAS #
C₅₀H₇₃N₁₅O₁₁ 58-82-2

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
05-23-0500-1MGCN
在庫状況検索中…
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      ガラスビン 1 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      05-23-0500-25MGCN
      在庫状況検索中…
      現在国内在庫なし現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください
          Contact Customer Service

          樹脂アンプル 25 mg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          05-23-0500-5MGCN
          在庫状況検索中…
          現在国内在庫なし現在国内在庫なし
          現在国内在庫有り 
          販売中止
          在庫僅少
          現在国内在庫あり
            Remaining : Will advise
              Remaining : Will advise
              注文対象外
              お問合せください
              Contact Customer Service

              樹脂アンプル 5 mg
              価格を検索中…
              価格が見つかりません
              Minimum Quantity needs to be mulitiple of
              弊社照会 詳細を表示 
              値引
              ()
               
              弊社照会
              Description
              OverviewInduces the release of nitric oxide. Other physiological functions include stimulation of pain receptors, inhibition of cAMP accumulation, and induction of smooth muscle contraction and vasodilation. Also involved in edema resulting from trauma or injury. Improves post-ischemic recovery of heart via a nitric oxide-dependent mechanism.
              Catalogue Number05-23-0500
              Brand Family Calbiochem®
              SynonymsRPPGFSPFR
              References
              ReferencesMombouli, J.V., and Vanhoutte, P.M. 1995. Am. J. Hypertens. 8, 195.
              Zhu, P., et al. 1995. Cardiovasc. Res. 29, 658.
              Bedarida, G.V., et al. 1994. Horm. Metab. Res. 26, 109.
              Altiok, N., and Fredholm, B.B. 1993. Cell Signal. 5, 279.
              Product Information
              CAS number58-82-2
              ATP CompetitiveN
              FormWhite to off-white lyophilized solid
              FormulationSupplied as an acetate salt.
              Hill FormulaC₅₀H₇₃N₁₅O₁₁
              Chemical formulaC₅₀H₇₃N₁₅O₁₁
              Hygroscopic Hygroscopic
              ReversibleN
              Sold on the basis of peptide contentY
              Quality LevelMQ100
              Applications
              Biological Information
              Primary TargetInduces the release of nitric oxide
              Purity≥97% by HPLC
              Physicochemical Information
              Cell permeableN
              Peptide ContentY
              Peptide SequenceH-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH
              Dimensions
              Materials Information
              Toxicological Information
              Safety Information according to GHS
              RTECSEE1530000
              Safety Information
              Product Usage Statements
              Storage and Shipping Information
              Ship Code Ambient Temperature Only
              Storage -20°C
              Hygroscopic Hygroscopic
              Do not freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
              Packaging Information
              Transport Information
              Supplemental Information
              Specifications

              Documentation

              Bradykinin - CAS 58-82-2 - Calbiochem (M)SDS

              タイトル

              英語版製品安全データシート((M)SDS) 

              Bradykinin - CAS 58-82-2 - Calbiochem 試験成績書(CoA)

              タイトルロット番号
              05-23-0500

              参考資料

              参考資料の概要
              Mombouli, J.V., and Vanhoutte, P.M. 1995. Am. J. Hypertens. 8, 195.
              Zhu, P., et al. 1995. Cardiovasc. Res. 29, 658.
              Bedarida, G.V., et al. 1994. Horm. Metab. Res. 26, 109.
              Altiok, N., and Fredholm, B.B. 1993. Cell Signal. 5, 279.
              データシート

              Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

              Revision18-September-2008 RFH
              SynonymsRPPGFSPFR
              DescriptionInduces the release of nitric oxide. Other physiological functions include stimulation of pain receptors, inhibition of cAMP accumulation, induction of smooth muscle contraction, and vasodilation. Also involved in edema resulting from trauma or injury. Improves post-ischemic recovery of heart via a nitric oxide-dependent mechanism.
              FormWhite to off-white lyophilized solid
              FormulationSupplied as an acetate salt.
              CAS number58-82-2
              RTECSEE1530000
              Chemical formulaC₅₀H₇₃N₁₅O₁₁
              Peptide SequenceH-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH
              Purity≥97% by HPLC
              Solubility5% acetic acid (1 mg/ml)
              Storage -20°C
              Hygroscopic
              Do Not Freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
              Merck USA index14, 1359
              ReferencesMombouli, J.V., and Vanhoutte, P.M. 1995. Am. J. Hypertens. 8, 195.
              Zhu, P., et al. 1995. Cardiovasc. Res. 29, 658.
              Bedarida, G.V., et al. 1994. Horm. Metab. Res. 26, 109.
              Altiok, N., and Fredholm, B.B. 1993. Cell Signal. 5, 279.